Top Markets
#1 Derive Derive +33.82%
#2 Cross Cross +15.09%
#3 Geodnet Geodnet +13.37%
#4 Gama Token Gama Token +9.17%
#5 Talus Network Talus Network +8.96%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.42%
#7 Cap Cap +6.96%
#8 Audiera Audiera +5.78%
#9 OVERTAKE OVERTAKE +5.63%
#10 Ontology Gas Ontology Gas +5.54%
Coin of the day
Derive Derive
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Classifica tra le azioni #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Prezzo delle azioni
$0.94
Ultima sincronizzazione: 2025-02-28
Capitalizzazione di mercato
$2.73M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Fresh Tracks Therapeutics, Inc. (FRTX)

Categoria

Healthcare
Numero di azioni in circolazione per Fresh Tracks Therapeutics, Inc. (FRTX)
Numero di azioni in circolazione al December 2023: 5.91M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Fresh Tracks Therapeutics, Inc., il numero attuale di azioni in circolazione è 5.91M. Alla fine del December 2022, la società aveva 2.81M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Fresh Tracks Therapeutics, Inc. (FRTX) dal 2000 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
2026 (TTM) 5.91M 0.00%
2023 5.91M 110.56%
2022 2.81M 57.33%
2021 1.78M 227.63%
2020 544.76K 710.92%
2019 67.18K -3.12%
2018 69.34K 69.47%
2017 40.91K 28.64%
2016 31.81K 9.20%
2015 29.13K 3.33%
2014 28.19K 2.24%
2013 27.57K 1.02%
2012 27.29K 19.35%
2011 22.87K 19.88%
2010 19.07K 27.61%
2009 14.95K 18.14%
2008 12.65K 1.70%
2007 12.44K 24.67%
2006 9.98K 27.89%
2005 7.80K 8.31%
2004 7.20K 12.95%
2003 6.38K 0.06%
2002 6.37K 0.24%
2001 6.36K 1.74%
2000 6.25K 0.00%
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,194.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 951.71%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE